Clinical Trials in New York

Showing 14241-14260 of 22,668 trials

MIRODERM H2H DFU Study

NCT03232333

This study will assess the ability of MIRODERM to heal difficult diabetic foot ulcers within 12 weeks of treatment.

Miromatrix Medical Inc.53 participantsStarted Jul 2017

Carlsbad, California, United States • Winter Haven, Florida, United States • Avon, Indiana, United States +6 more locations

COMPLETEDPhase 2< 1 mile

Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea

NCT01130272

The purpose of this study is to determine the efficacy, safety, and tolerability of different doses of JNJ-27018966 (eluxadoline) compared with placebo in the treatment of patients with irritable bowel syndrome with diarrhea (IBS-d).

Irritable Bowel Syndrome

Furiex Pharmaceuticals, Inc807 participantsStarted Apr 2010

Anniston, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +285 more locations

MIRODERM H2H DFU Study

Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea

Find Trials by Condition in New York

Dose-ranging Study of Nemolizumab in Atopic Dermatitis

Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor

Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella

MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

Motivational Interviewing for Getting Healthy TodaY Study

Dexamethasone for the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Cesarean Sections

A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal Irradiation

Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure

A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)

A Study of Sensitizing Potential of Diacerein 1% Ointment in Healthy Subjects

Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Ad26.ZIKV.001 in Healthy Adult Volunteers

Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function

Dose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection